Industry

Talus Bioscience

A drug discovery company targeting the regulome, the transcription factors controlling gene expression, using live-cell chemoproteomics and AI.

Location: Seattle, WA, USA
Website
1 model(1 Protein, 1 Small molecule)

Models (1)

Ptarmigan-1

Talus Bioscience

Released July 30, 2026

Structure-free virtual screening model co-embedding protein residues and small molecules from sequence and 2D chemistry, scoring a compound in 10 ms.

ProteinSmall molecule